Cell Based Assay Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 6.52 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Cell Based Assay Market Analysis
The cell-based assay market is expected to register a CAGR of 6.52% over the forecast period.
COVID-19 had a significant impact on the growth of the market. the cell-based assays are useful to discover inhibitors of the COVID-19 virus infection. According to the article titled "A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependant RNA polymerase" published in June 2021 cell-based assay is used to evaluate the efficacy of nucleotide analog compounds against SARS-CoV-2 RdRp and the assay is used to assess their tolerance to viral exoribonuclease-mediated proofreading. Thus COVID-19 propelled the demand for cell-based assays during the pandemic period.
The cell-based assay market is expected to show rapid growth due to the rising prevalence of chronic diseases and lifestyle disorders, increasing investments in R&D for drug discovery, and the rise in technological advancements in cell-based methodologies.
The rising prevalence of chronic diseases and lifestyle disorders, such as cancer, cardiovascular, diabetes, and neurological disorders is one of the primary factors fueling the market growth. The report published by International Agency for Research on Cancer (IARC) in December 2020 that the global cancer burden has risen to 19.3 million cases. Additionally, according to estimates from the International Agency for Research on Cancer (IARC), by 2040, the global burden of cancers is expected to grow to 27.5 million new cancer cases. And thus, due to the high incidence of cancer around the world, the demand for effective therapy or treatment is increasing which is expected to drive the growth of the cell-based assay market during the forecast period.
According to the data published by the European Heart network in 2021 reported that in the European Union more than 60 million people live with cardiovascular disease and close to 13 million new cases of cardiovascular diseases are diagnosed every year. Thus, the rise in chronic diseases leads to demand growth for cell-based assays for new drug discoveries, making it a vital factor for market growth. In addition, the demand for cell-based assays has increased significantly owing to a surge in cell-based applications in drug discovery and the rise in technological advancements in cell-based assay methodologies.
Additionally, innovative product launches by key market players are expected to drive the growth of the market. For instance, in May 2021, Viskol launched DILI 3D cell culture assay services using corning-qualified 3D PHH spheroid assay-ready plates.
Thus the above-mentioned factors are expected to drive the growth of the market during the forecast period. However, high maintenance and operational costs are expected to hinder the growth of the market.
Cell Based Assay Market Trends
This section covers the major market trends shaping the Cell-Based Assay Market according to our research experts:
Drug Discovery is Expected to be the Fast Growing Segment in the Cell-Based Assay Market Over the Forecast Period
The drug discovery segment is anticipated to show high growth in the market and this growth can be attributed to the increase in the R&D investment by biopharmaceutical companies. In addition, the rise in the prevalence of chronic diseases, such as cancer, osteoarthritis, cardiovascular diseases, and diabetes, is fueling the demand for cell-based assays for newer drug discoveries, making it a vital factor for the growth of this market. According to the article titled " 2022 Funding forecast: strong R&D growth with clouds on the horizon" published in April 2022 the United States federal government is expected to invest USD 181.4 billion in research and development in 2022. Such investment in research and development are expected to contribute to the growth of the studied segment over the forecast period.
In cell-based assays, functional cells are used as diagnostic tools in research for new drugs that help in drug discovery. The increasing market players' activities such as partnerships and collaborations for drug discovery are expected to drive the growth of the studied segment during the forecast period. For instance, in February 2021, Selvitalaunched the cell-based phenotypic assay platform for drug discovery. The platform will be used to test new compounds with therapeutic potential in multiple areas.
Furthermore, In June 2020, PhenoVista Biosciences collaborated with Olympus to deliver 3D cell-based assay services for drug discovery.
Thus the above-mentioned factors are expected to drive the demand for the growth of the studied segment during the forecast period.
North America is Expected to Dominate the Cell-Based Assay Market During the Forecast Period
North America is the dominating region across the world in terms of market share owing to the well-established healthcare sector along with the high adoption of cell-based assays. In the United States, the prevalence of chronic diseases, such as cancer, osteoarthritis, and diabetes, is increasing which is fueling the demand for cell-based assays for newer drug discoveries, making it a vital factor for the growth of this market.For instance, in the Cancer Facts & Figures 2022 data published by the American Cancer Society, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States.
Similarly, the American Heart Association in January 2022 mentioned that approximately every 40 seconds, someone in the United States will have a myocardial infarction. Such a high frequency of chronic diseases among the United States population is expected to drive the growth of the market during the forecast period.
Additionally, the market players activities for the development of cell based assays is expected to growth of the market in this region. For instance , in March 2022, Promega Corporation Collaborated with the FUJIFILM cellular dynamics to create novel assays to observe cellular biology in a system that better reflects how cells behave in the human body.
Thus the above-mentioned factors are expected to drive the growth of the market in this region during the forecast period.
Cell Based Assay Industry Overview
The cell-based assay market is moderately fragmented in nature due to the presence of several companies operating globally as well as regionally. The key players operating in the global cell-based assay market are Becton, Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific, Inc., General Electric Company, Merck KGaA, Perkinelmer, Inc., Bio-Rad Laboratories, Inc., and Promega Corporation.
Cell Based Assay Market Leaders
-
Becton, Dickinson and Company
-
Bio-Rad Laboratories, Inc.
-
Corning Inc.
-
Merck KGaA
-
Thermo Fisher Scientific Inc.
*Disclaimer: Major Players sorted in no particular order
Cell Based Assay Market News
- In August 2022, Life Net Health LifeSciences launched the Cell-Based Assay Services including cytotoxicity screening, biocompatibility assays, and others
- In May 2022, Beckman Coulter Life Sciences launched the Aquios STEM system to provide a new solution for stem cell analysis. This innovation significantly reduces the turnaround time while decreasing manual and error-prone steps.
Cell Based Assay Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Prevalence of Chronic Diseases and Lifestyle Disorders
- 4.2.2 Increasing Investments in R&D for Drug Discovery
- 4.2.3 Rise in Technological Advancements in Cell-based Methodologies
-
4.3 Market Restraints
- 4.3.1 High Maintenance and Operational Costs
- 4.3.2 Lack of Skilled Personnel to Operate these Technologies
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product
- 5.1.1 Cell Lines
- 5.1.1.1 Primary Cell Lines
- 5.1.1.2 Stem Cell Lines
- 5.1.1.3 Others
- 5.1.2 Reagents and Kits
- 5.1.3 Microplates
- 5.1.4 Other Consumables
-
5.2 By Technology
- 5.2.1 Automated Handling
- 5.2.2 Flow Cytometry
- 5.2.3 Label-free Detection
- 5.2.4 High-throughput Screening
- 5.2.5 Others
-
5.3 By Application
- 5.3.1 Drug Discovery
- 5.3.2 Other Applications
-
5.4 By End-user
- 5.4.1 Academic & Government Institutes
- 5.4.2 Pharmaceutical and Biotechnology Companies
- 5.4.3 Others
-
5.5 Geography
- 5.5.1 North America
- 5.5.1.1 United States
- 5.5.1.2 Canada
- 5.5.1.3 Mexico
- 5.5.2 Europe
- 5.5.2.1 Germany
- 5.5.2.2 United Kingdom
- 5.5.2.3 France
- 5.5.2.4 Italy
- 5.5.2.5 Spain
- 5.5.2.6 Rest of Europe
- 5.5.3 Asia-Pacific
- 5.5.3.1 China
- 5.5.3.2 Japan
- 5.5.3.3 India
- 5.5.3.4 Australia
- 5.5.3.5 South Korea
- 5.5.3.6 Rest of Asia-Pacific
- 5.5.4 Middle East and Africa
- 5.5.4.1 GCC
- 5.5.4.2 South Africa
- 5.5.4.3 Rest of Middle East and Africa
- 5.5.5 South America
- 5.5.5.1 Brazil
- 5.5.5.2 Argentina
- 5.5.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Becton, Dickinson and Company
- 6.1.2 Bio-Rad Laboratories, Inc.
- 6.1.3 Corning Inc.
- 6.1.4 Danaher Corporation
- 6.1.5 Thermo Fisher Scientific Inc.
- 6.1.6 Merck KGaA
- 6.1.7 Perkin Elmer Inc.
- 6.1.8 Promega Corporation
- 6.1.9 Lonza Group
- 6.1.10 Cell Singnalling Technology
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityCell Based Assay Industry Segmentation
As per the scope of the report, cell-based assays are versatile research lab tools used in healthcare. These tools are designed to target specific cells by using antibodies or other moieties, to determine the functionality and efficacy of drugs. Also, cell-based assays help to measure cell motility, and proliferation and facilitate research in the area of stem cells, immunology, cancer, and others. The cell-based assay market is segmented by Product (Cell Lines (Primary Cell Lines, Stem Cell Lines, and Others), Reagents and Kits, Microplates, and Other Consumables), Technology (Automated Handling, Flow Cytometry, label-Free Detection, High-throughput Screening, and Others), Application (Drug Discovery and Other Applications), End-user (Academic and Government Institutes, Pharmaceutical and Biotechnology Companies and Others) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Product | Cell Lines | Primary Cell Lines |
| Stem Cell Lines | ||
| Others | ||
| By Product | Reagents and Kits | |
| Microplates | ||
| Other Consumables | ||
| By Technology | Automated Handling | |
| Flow Cytometry | ||
| Label-free Detection | ||
| High-throughput Screening | ||
| Others | ||
| By Application | Drug Discovery | |
| Other Applications | ||
| By End-user | Academic & Government Institutes | |
| Pharmaceutical and Biotechnology Companies | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Cell Based Assay Market Research FAQs
What is the current Global Cell-Based Assay Market size?
The Global Cell-Based Assay Market is projected to register a CAGR of 6.52% during the forecast period (2024-2029)
Who are the key players in Global Cell-Based Assay Market?
Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Corning Inc., Merck KGaA and Thermo Fisher Scientific Inc. are the major companies operating in the Global Cell-Based Assay Market.
Which is the fastest growing region in Global Cell-Based Assay Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Cell-Based Assay Market?
In 2024, the North America accounts for the largest market share in Global Cell-Based Assay Market.
What years does this Global Cell-Based Assay Market cover?
The report covers the Global Cell-Based Assay Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Cell-Based Assay Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Pet Obesity Management Industry Report
Statistics for the 2024 Pet Obesity Management market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Pet Obesity Management analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
